However, EZH2 can behave also oppositely in the regulation of NF-kB target gene expression, depending on the cellular context, as the same authors provided evidence that in the ER-positive luminal-like breast cancer cells, EZH2 negatively regulated NF-kB target genes [46]. The gene discussed is EZH2; the disease is breast carcinoma.